| Literature DB >> 26635016 |
Koji Hosokawa1, Masaji Nishimura2, Moritoki Egi3, Jean-Louis Vincent4.
Abstract
INTRODUCTION: The optimal timing of tracheotomy in critically ill patients remains a topic of debate. We performed a systematic review to clarify the potential benefits of early versus late tracheotomy.Entities:
Mesh:
Year: 2015 PMID: 26635016 PMCID: PMC4669624 DOI: 10.1186/s13054-015-1138-8
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Summary of the included randomized controlled trials of early versus late tracheotomy
| Study | Patients | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Definition of early versus late tracheotomya(days) | Type of ICU; number of ICUs | Number of patients, early versus late groups | Inclusion criteria | Excluded | Major disease category | APACHE II/SAPS II | Tracheotomy rate (number (%)) in early versus late groups | Percutaneous dilatation tracheotomy (number (%)) in early versus late groups | |
| Saffle et al. (2002) [ | 2-4 vs. 14–16 | Burn; 1 | 21 vs. 23 | High predicted probability of prolonged MV | Burn (100 %) | NA | 21 (100 %) vs. 16 (70 %) | NA | |
| Rumbak et al. (2004) [ | ≤2 vs. >14 | Medical; 2 | 60 vs. 60 | exp. >14 d MV; APACHE II >25 | Respiratory failure (100 %), severe sepsis (68 %) | 26.9 | 60 (100 %) vs. 50 (83 %) | All in both groups | |
| Barquist et al. (2006) [ | <8 vs. >28 | Trauma; 1 | 29 vs. 31 | GCS >4 with no head injury; GCS >9 with head injury | Trauma (100 %) | 12.6 | 27 (93 %) vs. 11 (35 %) | 0/27 (0 %) vs. 0/11 (0 %) | |
| Blot et al. (2008) [ | ≤4 vs. >14 | Medical and surgical; 25 | 61 vs. 62 | exp. >7 d MV | Irreversible neurological disease | Respiratory failure (33 %), neurology (23 %), trauma (19 %) | NA/50 | 60 (98 %) vs. 16 (26 %) | 19/60 (32 %) vs. 7/16 (44 %) |
| Terragni et al. (2010) [ | 6-8 vs. 13–15 | NA; 12 | 209 vs. 210 | SAPS II = 35–65; SOFA ≥5; worsening respiratory conditions; unchanged/worse SOFA sore | Pneumonia (CPIS ≥6); COPD | Respiratory failure (46 %), neurology (24 %), cardiovascular disease (23 %) | NA/50.4 | 145 (69 %) vs. 119 (57 %) | 141/145 (97 %) vs. 113/119 (95 %) |
| Trouillet et al. (2011) [ | <5-7 vs. >19 | Surgical; 1 | 109 vs. 107 | exp. >7 d MV | Irreversible neurologic disorder | Post-cardiac surgery (100 %) | NA/46.5 | 109 (100 %) vs. 29 (27 %) | All in both groups |
| Zheng et al. (2012) [ | 3 vs. 15 | Surgical; 1 | 58 vs. 61 | PaO2/FiO2 <200; APACHE II >15;SOFA >5; CPIS >6; exp. >14 d MV | Pulmonary infection (CPIS >6) | NA | 20.0 | 58 (100 %) vs. 51 (84 %) | All in both groups |
| Koch et al. (2012) [ | ≤4 vs. ≥6 | Surgical; 1 | 50 vs. 50 | exp. >21 d MV | Pneumonia | Neurosurgical (28 %), trauma (25 %) | 22 | All in both groups | All in both groups |
| Young et al. (2013) [ | ≤4 vs. >10 | General;70 and surgical; 2 | 451 vs. 448 | exp. >7 d MV | Respiratory failure due to chronic neurological disease | Pulmonary (60 %), gastrointestinal (19 %) | 19.8 | 418 (93 %) vs. 204 (46 %) | 378/418 (90 %) vs. 176/204 (86 %) |
| Bösel et al. (2013) [ | ≤3 vs. 7–14 | Neuro; 1 | 30 vs. 30 | ICH; SAH; or AIS; exp. >14 d MV | Severe chronic cardiopulmonary disease; extensive brainstem lesions | Non-traumatic neurology (100 %) | 17 | 30 (100 %) vs. 18 (60 %) | 27/30 (90 %) vs. 16/18 (89 %) |
| Mohamed et al. (2014) [ | ≤10 vs. >10 | NA; 2 | 20 vs. 20 | APACHE ≥15 | Pneumonia | TBI (43 %), CVA (25 %) | 24 | All in both groups | All in both groups |
| Diaz-Prieto et al. (2014) [ | <8 vs. >14 | NA; 4 | 245 vs. 244 | 1, exp. >7 d MV; 2, attending physician’s acceptance at 3–5 d | Respiratory insufficiency (60 %), coma (22 %) | 20 | 167 (68 %) vs. 135 (55 %) | All in both groups | |
aValues are shown as days from the initiation of mechanical ventilation, except one that used days from ICU admission [19]. AIS acute ischemic stroke, APACHE acute physiology and chronic health evaluation, COPD chronic obstructive pulmonary disease, CPIS clinical pulmonary infection score, CVA cerebrovascular accident, d days, exp. expected, GCS Glasgow coma scale, ICH intracerebral hemorrhage, MV mechanical ventilation, NA not available, PaO /FiO partial pressure arterial oxygen/fraction of inspired oxygen, RCT randomized controlled trial, SAH subarachnoid hemorrhage, SAPS simplified acute physiology score, SOFA sequential organ failure assessment
Fig. 1Tracheostomy rate. Meta-analysis of the 12 studies. I-V inverse variance
Reported outcomes in the included randomized controlled trials
| Duration of mechanical ventilation, early versus late groups (days) | Number of ventilator-free days in 28 days, early versus late groups | Duration of ICU stay, early versus late groups (days) | Number of ICU-free days in 28 days, early versus late groups | Duration of sedation, early versus late groups (days) | Number of sedation-free days in 28 days, early versus late groups | Acquired pneumonia, early versus late groups | Mortality (≤2 months), early versus late groups | Mortality (>2 months), early versus late groups | Other outcomes, early versus late groups, | |
|---|---|---|---|---|---|---|---|---|---|---|
| Saffle et al. (2002) [ | 35.5 (4.5) vs. 31.4 (5.2) ( | NA | NA | NA | NA | NA | 21 (100 %) vs. 22 (96 %) ( | 17 (81 %) vs. 17 (74 %) ( | NA | Successfully extubated, 1 (5 %) vs. 6 (26 %) ( |
| Rumbak et al. (2004) [ | 7.6 (4.0) vs. 17.4 (5.3) ( | NA | 4.8 (1.4) vs. 16.2 (3.8) ( | NA | 3.2 (0.4) vs. 14.1 (2.9) ( | NA | 3 (5 %) vs. 15 (25 %) ( | 19 (32 %) vs, 37 (62 %) ( | NA | Damage to the larynx and lips, rated 0–1 vs. 2–3 |
| Barquist et al. (2006) [ | NA | 8.57 (7.9) vs. 8.83 (9) (in 30 d) ( | NA | 5.0 (6.0) vs. 5.3 (6.5) (in 30 d) ( | NA | NA | 28 (97 %) vs. 28 (90 %) ( | 2 (6.9 %) vs. 5 (16 %) (p = 0.4) | NA | |
| Blot et al. (2008) [ | 14 (2–28) vs. 16 (3–28) ( | NA | NA | NA | NA | 18 (0–27) vs. 15 (0–27) | 30 (49 %) vs. 31 (50 %) ( | 12 (20 %) vs. 15 (24 %) (at 28 d); 16 (27 %) vs. 15 (24 %) (at 60 d) | NA | Laryngeal symptoms, 1 (2 %) vs. 7 (11 %) ( |
| Terragni et al. (2010) [ | NA | 11 (0–21) vs. 6 (0–17) ( | NA | 0 (0–13) vs. 0 (0-8) ( | NA | NA | 30 (14 %) vs. 44 (21 %) ( | 55 (26 %) vs. 66 (31 %) ( | 72/144 (50 %) vs. 75/138 (57 %)( | Successful weaning, 161 (77 %) vs. 142 (68) |
| Trouillet et al. (2011) [ | 17.9 (14.9) vs. 19.3 (16.9) ( | 10.0 (8.8) vs. 9.2 (10.2) ( | 23.9 (21.3) vs. 25.5 (22.2) ( | NA | 6.4 (5.9) vs. 9.6 (7.3) ( | 19.0 (9.1) vs. 15.5 (9.3) ( | 50 (46 %) vs. 47 (44 %) ( | 17 (16 %) vs. 23 (21 %) ( | 12/74 (16 %) vs. 17/74 (23 %) ( | ADL, anxiety, depression, or PTSD, similar |
| Zheng et al. (2012) [ | NA | 9.6 (5.6) vs. 7.4 (6.2) (p = 0.05) | NA | 8.0 (5.0–12.0) vs. 3.0 (0–12.0) ( | NA | 20.8 (2.4) vs. 17.1 (2.3) ( | 17 (29 %) vs. 30 (49 %) ( | 8 (14 %) vs. 6 (10 %) ( | NA | |
| Koch et al. (2012) [ | 15.3 (9.1–19.8) vs. 21.1 (13.5–27.9) ( | NA | 21.5 (15.0–30.0) vs. 30.6 (22.0–37.0) ( | NA | NA | NA | 19 (38 %) vs. 32 (64 %) | 9 (18 %) vs. 7 (14 %) ( | 10 (20 %) vs. 11(22 %) ( | |
| Young et al. (2013) [ | 13.6 (12.0) vs. 15.2 (14.4) ( | NA | 13.0 (8.2–19.1) vs. 13.1 (7.4–23.6) ( | NA | 5 (3–9) vs. 8 (4–12) ( | NA | NA | 139 (31 %) vs. 141 (32 %) ( | 168 (40 %) vs. 180 (41 %) ( | Antibiotic use, 5 (1–8) vs. 5 (1–10) ( |
| Bösel et al. (2013) [ | 15 (10–17) vs. 12 (8–16) ( | NA | 17 (13–22) vs. 18 (16–28) ( | NA | NA | NA | NA | 3 (10 %) vs. 14 (47 %) ( | 8 (27 %) vs. 18 (0.6 %) ( | Sedation use (42 %) vs. (62 %) ( |
| Mohamed et al. (2014) [ | 20.6 (13.0) vs. 32.2 (10.5) ( | NA | 21.1 (13.5) vs. 40.2 (12.7) ( | NA | NA | NA | 4 (20 %) vs. 8 (40 %) | NA | 8 (40 %) vs. 8 (40 %) (in hospital) | |
| Diaz-Prieto et al. (2014) [ | NA | 11 (0–22) vs. 9 (0–22) ( | 22 (6–101) 22.5 (6–174) ( | NA | 11 (2–92) vs. 14 (0–79) ( | NA | 33 (13 %) vs. 23 (9 %) ( | 42 (17 %) vs. 47 (19 %) ( | 63 (26 %) vs. 73 (30 %) ( | Excluded by attending physician, 284 (58 %) |
The values are presented as number (%), mean with (SD) or median with (IQR). The values indicate early tracheostomy versus late tracheostomy
ADL activities of daily living, d days, NA not available, PTSD posttraumatic stress disorder, RCT randomized controlled trial
Fig. 2a Duration of mechanical ventilation. Meta-analysis of the eight studies providing this information. b Ventilator-free days. Meta-analysis of the five studies providing this information. I-V inverse variance
Fig. 3a Duration of sedation. Meta-analysis of the four studies providing this information. b Sedation-free days. Meta-analysis of the three studies providing this information. I-V inverse variance
Fig. 4a Short-term mortality. Meta-analysis of the 11 studies providing this information. b Long-term mortality. Meta-analysis of the 7 studies providing this information. Data for 28-day, 30-day and ICU mortality were combined to show short-term mortality, and data for 1-year, 6-month and hospital mortality were combined as long-term mortality. I-V inverse variance